Nu Skin Enterprises (NYSE:NUS) Updates FY 2025 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 0.900-1.300 for the period, compared to the consensus earnings per share estimate of 0.760. The company issued revenue guidance of $1.5 billion-$1.6 billion, compared to the consensus revenue estimate of $1.7 billion. Nu Skin Enterprises also updated its Q1 2025 guidance to 0.100-0.200 EPS.

Nu Skin Enterprises Stock Up 1.3 %

Shares of NYSE NUS traded up $0.09 during mid-day trading on Thursday, reaching $6.41. The company had a trading volume of 1,299,428 shares, compared to its average volume of 687,522. The stock has a fifty day moving average of $6.91 and a two-hundred day moving average of $7.50. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.20 and a current ratio of 1.93. The company has a market capitalization of $318.40 million, a price-to-earnings ratio of -3.09 and a beta of 1.17. Nu Skin Enterprises has a 12-month low of $5.95 and a 12-month high of $17.68.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings data on Thursday, February 13th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.14. Nu Skin Enterprises had a negative net margin of 5.81% and a positive return on equity of 5.47%. As a group, equities research analysts expect that Nu Skin Enterprises will post 0.68 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on NUS. StockNews.com raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Monday, November 11th. Citigroup cut their price objective on shares of Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating on the stock in a research report on Tuesday, October 22nd. Finally, DA Davidson cut their price objective on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a research report on Friday, December 20th.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.